Literature DB >> 12170333

[Immunopathology of leprosy: the complexity of the mechanisms of host immune response to Mycobacterium leprae].

Isabela Maria Bernardes Goulart1, Gerson Oliveira Penna, Gabriel Cunha.   

Abstract

Leprosy, whose etiologic agent Mycobacterium leprae, is an illness of ample clinical and immunopathological spectrum. Its clinical manifestations are correlated with distinct immunologic forms, varying from a vigorous immune response mediated by cells to M. leprae, with Th1 standard in the tuberculoid polar region, to an absence of specific cellular response to antigens of M. leprae in the lepromatous polar region, with predominance of Th2 response and exacerbation of humoral response. It is probable that different polymorphic genes determine susceptibility to M. leprae. Additional studies are necessary to clarify the complex interactions between cytokines and the role of the phenotypic diversity of cells network that contribute to the host defense. The comprehension of such mechanisms will provide new insights for the identification of agonists and/or antagonists for pro- or anti-inflammatory effects, and also will indicate possible situations for its appropriate use in immunologic and/or immunotherapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170333     DOI: 10.1590/s0037-86822002000400014

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  14 in total

1.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.

Authors:  L N Dornelles; L Pereira-Ferrari; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

3.  Presence of intestinal helminths decreases T helper type 1 responses in tuberculoid leprosy patients and may increase the risk for multi-bacillary leprosy.

Authors:  L M Diniz; E F L Magalhães; F E L Pereira; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

4.  Association of cytokine gene polymorphism with susceptibility and clinical types of leprosy.

Authors:  A Settin; S Nassar; A Abdel-Latif; R Elbaz; S El-Mongy; Aa Hassan; Am Hassan
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

5.  A novel integrated molecular and serological analysis method to predict new cases of leprosy amongst household contacts.

Authors:  Rafael Silva Gama; Márcio Luís Moreira de Souza; Euzenir Nunes Sarno; Milton Ozório de Moraes; Aline Gonçalves; Mariane M A Stefani; Raúl Marcel González Garcia; Lucia Alves de Oliveira Fraga
Journal:  PLoS Negl Trop Dis       Date:  2019-06-10

6.  Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy.

Authors:  Marlice Fernandes de Oliveira; Douglas Eulálio Antunes; Diogo Fernandes Dos Santos; Isabela Maria Bernardes Goulart
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

7.  Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin.

Authors:  Mônica Santos; Emily dos Santos Franco; Paulo Luis da Costa Ferreira; Wornei Silva Miranda Braga
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

Review 8.  Epidemiological situation of leprosy in Salvador from 2001 to 2009.

Authors:  Shirlei Cristina Moreira; Claudilson José de Carvalho Batos; Lara Tawil
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

9.  Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy.

Authors:  Douglas Eulálio Antunes; Sergio Araujo; Gabriela Porto Ferreira; Ana Carolina Sousa Rodrigues da Cunha; Adeilson Vieira da Costa; Maria Aparecida Gonçalves; Isabela Maria Bernardes Goulart
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-11       Impact factor: 2.743

10.  Leprosy: a review of laboratory and therapeutic aspects--part 2.

Authors:  Joel Carlos Lastória; Marilda Aparecida Milanez Morgado de Abreu
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.